Trial Profile
To evaluate pharmacokinetics of darunavir/ritonavir in HIV-1-infected pregnant women.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Aug 2017
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 18 Aug 2017 New trial record